PICAROS - Acalabrutinib RWE on 1L CLL in Spain

Active, not recruitingOBSERVATIONAL
Enrollment

192

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Lymphocytic Leukemia
Trial Locations (47)

3010

Research Site, Alicante

4009

Research Site, Almería

7010

Research Site, Palma de Mallorca

7198

Research Site, Palma de Mallorca

8003

Research Site, Barcelona

8025

Research Site, Barcelona

8035

Research Site, Barcelona

8036

Research Site, Barcelona

8221

Research Site, Terrassa

8402

Research Site, Granollers

8908

Research Site, L'Hospitalet de Llobregat

14004

Research Site, Córdoba

15706

Research Site, Santiago de Compostela

18014

Research Site, Granada

19002

Research Site, Guadalajara

23007

Research Site, Jaén

25198

Research Site, Lleida

28006

Research Site, Madrid

28031

Research Site, Madrid

28034

Research Site, Madrid

28040

Research Site, Madrid

28041

Research Site, Madrid

28046

Research Site, Madrid

28222

Research Site, Majadahonda

28905

Research Site, Madrid

28911

Research Site, Madrid

29010

Research Site, Málaga

29603

Research Site, Marbella

30008

Research Site, Murcia

30120

Research Site, El Palmar

32005

Research Site, Ourense

33011

Research Site, Oviedo

35016

Research Site, Las Palmas de Gran Canaria

35019

Research Site, Las Palmas de Gran Canaria

36312

Research Site, Vigo

37007

Research Site, Salamanca

38320

Research Site, San Cristóbal de La Laguna

39008

Research Site, Santander

40002

Research Site, Segovia

41013

Research Site, Seville

45004

Research Site, Toledo

46010

Research Site, Valencia

46014

Research Site, Valencia

46026

Research Site, Valencia

47003

Research Site, Valladolid

47012

Research Site, Valladolid

50009

Research Site, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY